Mediolanum International Funds’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.06M Sell
24,347
-238,252
-91% -$12.9M 0.01% 406
2026
Q1
$16.5M Sell
262,599
-88,211
-25% -$7.06M 0.18% 148
2025
Q4
$33.7M Buy
350,810
+13,816
+4% +$1.35M 0.34% 65
2025
Q3
$32.7M Sell
336,994
-189,000
-36% -$19.6M 0.34% 64
2025
Q2
$56M Buy
525,994
+103,124
+24% +$10.4M 0.67% 26
2025
Q1
$42M Sell
422,870
-102,206
-19% -$10.3M 0.58% 35
2024
Q4
$47M Buy
525,076
+68,104
+15% +$6M 0.61% 32
2024
Q3
$38M Sell
456,972
-7,318
-2% -$577K 0.53% 36
2024
Q2
$33.4M Sell
464,290
-86,944
-16% -$6.36M 0.55% 36
2024
Q1
$37.8M Buy
+551,234
New +$35.4M 0.61% 33

Other funds holding BSX

Mediolanum International Funds's BSX Position: Q2 2026 in Review

Mediolanum International Funds reduced its Boston Scientific (BSX) stake by 91% in Q2 2026, selling an estimated $12.9M and leaving 24,347 shares worth $1.06M. The position accounts for 0.01% of the portfolio, ranked #406.

Mediolanum International Funds first reported a position in BSX in Q1 2024 and has held it in 10 quarters since. The position peaked at $56M in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Mediolanum International Funds held 24,347 shares of Boston Scientific worth $1.06M as of Q2 2026.
  • Mediolanum International Funds sold 238,252 Boston Scientific shares in Q2 2026, an estimated $12.9M.
  • Boston Scientific made up 0.01% of Mediolanum International Funds's portfolio in Q2 2026, its #406 holding.
  • Mediolanum International Funds first reported a position in Boston Scientific in Q1 2024 and has held it in 10 quarters since.
  • Mediolanum International Funds's Boston Scientific position peaked at $56M in Q2 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Mediolanum International Funds's 13F filing for Q2 2026, filed 23 Jul 2026.